A First-in-Human Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Novel Anti-Interleukin 1 Biologic Agent, Rph-104, in Healthy Subjects

Yazar
Gül, Ahmet
GÜRGÜN, CEMİL
Turk, Ugur Onsel
Senturk, Recep Selim
Ulker, Sibel
Altinel, Serdar
Ozen, Sebnem
Samsonov, Mikhail
Lavrovsky, Yan
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/140719
Koleksiyonlar